Peter van Schijndel

Peter is part of the team that founded HOYNG ROKH MONEGIER in 2011, and was made partner in 2017. He specializes in patent litigation, with a particular focus on the pharmaceutical, biotech and medical devices industry. Most of Peter’s cases have an international dimension, and he has extensive experience in coordinating multi-jurisdictional IP matters.

Representative clients in the pharmaceutical / biotechnology field include AbbVie, Abbott, Biogen, Johnson & Johnson, Gilead, Sanofi, Pfizer, UCB, and Regeneron.